Oragenics Inc (OGEN)
0.2706
-0.02
(-6.04%)
USD |
NYAM |
Nov 21, 16:00
0.2703
0.00 (0.00%)
After-Hours: 20:00
Oragenics Enterprise Value: 2.273M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.273M |
| November 20, 2024 | 2.485M |
| November 19, 2024 | 2.388M |
| November 18, 2024 | 2.510M |
| November 15, 2024 | 2.885M |
| November 14, 2024 | 2.985M |
| November 13, 2024 | 3.120M |
| November 12, 2024 | 3.065M |
| November 11, 2024 | 3.155M |
| November 08, 2024 | 3.302M |
| November 07, 2024 | 2.569M |
| November 06, 2024 | 2.502M |
| November 05, 2024 | 2.545M |
| November 04, 2024 | 2.502M |
| November 01, 2024 | 2.310M |
| October 31, 2024 | 2.428M |
| October 30, 2024 | 2.564M |
| October 29, 2024 | 2.546M |
| October 28, 2024 | 2.625M |
| October 25, 2024 | 2.509M |
| October 24, 2024 | 2.569M |
| October 23, 2024 | 2.642M |
| October 22, 2024 | 2.806M |
| October 21, 2024 | 2.851M |
| October 18, 2024 | 2.403M |
| Date | Value |
|---|---|
| October 17, 2024 | 2.391M |
| October 16, 2024 | 2.513M |
| October 15, 2024 | 2.113M |
| October 14, 2024 | 2.288M |
| October 11, 2024 | 2.707M |
| October 10, 2024 | 3.046M |
| October 09, 2024 | 3.003M |
| October 08, 2024 | 2.348M |
| October 07, 2024 | 2.690M |
| October 04, 2024 | 2.911M |
| October 03, 2024 | 2.721M |
| October 02, 2024 | 2.723M |
| October 01, 2024 | 2.660M |
| September 30, 2024 | 2.547M |
| September 27, 2024 | 3.682M |
| September 26, 2024 | 3.725M |
| September 25, 2024 | 3.881M |
| September 24, 2024 | 4.227M |
| September 23, 2024 | 4.292M |
| September 20, 2024 | 4.400M |
| September 19, 2024 | 4.400M |
| September 18, 2024 | 4.426M |
| September 17, 2024 | 4.582M |
| September 16, 2024 | 4.548M |
| September 13, 2024 | 4.826M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.262M
Minimum
Mar 27 2023
142.74M
Maximum
Feb 12 2021
22.81M
Average
14.88M
Median
Enterprise Value Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | 3.326M |
| Johnson & Johnson | 389.84B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.463M |
| Total Expenses (Quarterly) | 2.437M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | -2.61K% |
| Normalized Earnings Yield | -33220.80 |